MedinCell S.A.

EPA:MEDCL.PA

16.3 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202320222021202020192018201720162015
Operating Activities:
Net Income -25.038-32.01-24.806-18.986-23.915-19.682-9.575-3.5370.585
Depreciation & Amortization 1.7191.6651.5161.341.2560.7750.6580.5520.331
Deferred Income Tax 0-10.204-6.788-5.6432.472-0.3670.893-1.008-0.123
Stock Based Compensation 2.8092.2792.3941.5631.660.0570.070.0360.051
Change In Working Capital 3.178-3.036-2.3670.6243.568-1.0370.781-1.412-0.875
Accounts Receivables 4.944-5.791-1.388-1.219-0.981-0.4640.8291.225-1.84
Inventory 00-0000.063-0.679-0.7590
Accounts Payables -2.3281.1960.026-0.181.4810.3790.4340.4980.69
Other Working Capital 0.5621.559-1.0052.0233.068-1.0150.197-2.3760.275
Other Non Cash Items 4.11715.8857.6585.5040.9614.3221.7471.9760.099
Operating Cash Flow -11.922-25.421-22.393-15.597-13.998-15.932-5.426-3.3930.068
Investing Activities:
Investments In Property Plant And Equipment -1.191-1.027-1.974-0.819-0.921-0.754-1.188-1.831-1.164
Acquisitions Net 0.0010.0480.0160-0.647-0.0550-0.0020
Purchases Of Investments 0-0.326-1.307-0.284-0.012-0.0920-6.083-0.351
Sales Maturities Of Investments 0.0242.5591.54700.930.0923.3746.570
Other Investing Activites 0-01.307-0.4170.647-0.0230.0560.0230.028
Investing Cash Flow -0.6131.254-0.411-1.103-0.003-0.8322.242-7.893-1.487
Financing Activities:
Debt Repayment -5.076-5.828-1-9.442-5.348-2.365-2.637-3.144-0.419
Common Stock Issued 23.3210.810.04842.2850.03922.7830.0310.020.021
Common Stock Repurchased -0.0250-0.1920-0.043-0.1190-0.0020
Dividends Paid 0000000-17.770
Other Financing Activities 011.0341.7418.57814.25929.2410.75935.5380.955
Financing Cash Flow 25.5286.0160.32651.4215.09729.248.15314.6420.557
Other Information:
Effect Of Forex Changes On Cash 00.001-2-0.003-0.0030.02-0.002-0.168-0.026
Net Change In Cash 12.993-13.15-24.47835.718-12.90712.4934.9673.188-0.888
Cash At End Of Period 19.466.46719.61744.0958.37721.2848.7913.8240.636